Partners

Gate2Brain receives €2.5M funding from the european innovation council to develop a new technology to treat brain cancer

The spin-off of IRB Barcelona, the UB and SJD has a patented technology based on peptides (small proteins) that efficiently cross biological barriers, such as the blood-brain barrier that protects the brain.

gate 2 brain
Healthcare
Access to innovation
Corporate

The spin-off of IRB Barcelona, ​​the UB and SJD developed a patented technology based on peptides (small proteins) that cross the blood-brain barrier.

These peptides act as molecular shuttles, carrying medicines to the brain.

The first indication that will benefit from the technology is a highly aggressive type of pediatric brain cancer.

As Meritxell Teixidó, CEO of Gate2Brain, explains, the 2.5 million euro received through the highly competitive EIC Accelerator program will be key to complete the preclinical regulatory studies of their therapeutic asset G2B-002. This development is being conducted in collaboration with the SJD Pediatric Cancer Center at Sant Joan de Déu Hospital, Barcelona, and targets the treatment of high-grade pediatric brain tumors. In two or three years, the technology will be evaluated in a clinical trial.

“Humankind has dreamed of traveling to the brain for decades and, in fact, science fiction has dedicated books and films such as Isaac Asimov's Fantastic Voyage. Gate2Brain's dream is to improve the health and quality of life of people suffering from central nervous system diseases by improving drug delivery to the brain", says Teixidó. “Today, just before Christmas, the dream is one step closer thanks to funding from the EIC Accelerator", she added.

EIC Accelerator is a program of the European Innovation Council (EIC) that supports individual Small and Medium Enterprises (SMEs), in particular startups and spin-offs, to develop and scale breakthrough innovations.

EIC Accelerator selected 78 innovative companies from among 1,092 startups and SMEs, of which 240 were interviewed by a panel of experienced investors and entrepreneurs. The selected companies will together receive close to €470 millions of funding in a combination of grants and equity investments. The program covers a geographical distribution of 17 countries and 15% of the selected companies are headed by women.

Gate2Brain is a spin-off of the Barcelona Biomedical Research Institute (IRB Barcelona), the University of Barcelona (UB) and the Sant Joan de Déu Hospital (SJD). The company was created in July 2020, thanks to the financial boost received from the Fundación Botín -through the Mind the Gap program-, Banco de Sabadell -through BStartup Health, and "la Caixa" Foundation -through CaixaResearch Consolidate-, and later the NEOTEC Program of the Center for Industrial Technological Development (CDTI).

sant joan

 

Más información en el documento adjunto.
Attached files
NdP Gate2Brain EIC Accelerator ESP.pdf591.84 KBDownload